AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Esophageal Pre-Cancer Testing Gaining Greater Traction
How three companies are addressing screening challenges with tests that help improve chances of early detection
Computing the Future of the Lab
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
Sequencing-Based Panel May Improve Evaluation of Thyroid Nodules
From - Diagnostic Testing & Emerging Technologies
A genetic test panel can help patients avoid unnecessary diagnostic thyroid surgeries, according to a study published Nov. 8 in…
At-Home, Smartphone-Based Urine Testing Now a Clinical Reality
From - Diagnostic Testing & Emerging Technologies
In what has been called the "era of the medical selfie," at-home, smartphone-based urine testing is now a reality. In a short timeframe, the…
Despite 23andMe Authorization, FDA Cautious About PGx Testing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Ideal Age of Last Cervical Cancer Screening Depends on Test Type
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
MSSA Screening Program Cuts Infections in NICUs
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Penicillin Allergy Testing Underused, Could Lead to Cost Savings
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
FDA Enabling New Point-of-Care Tests for Ebola Outbreak, Flu Season
From - Diagnostic Testing & Emerging Technologies
Several recent U.S. Food and Drug Administration (FDA) actions are bringing point-of-care (POC) infectious disease tests closer to…
6 Steps to Data-Driven Transformation
By Nir Kaldero bio
We're now well into the Fourth Industrial Revolution. The First Industrial Revolution was about steam and railroads, the Second about electricity, and the…
One-Fourth of Myriad’s Variants of Unknown Significance Reclassified Over 10 Years
From - Diagnostic Testing & Emerging Technologies
Variant reclassification following hereditary cancer genetic testing is common, according to a study published by…
Multiplex, Point-of-Care Test for STIs Could Offer Public Health Benefits
From - Diagnostic Testing & Emerging Technologies
Point-of-care (POC) testing that could simultaneously identify multiple sexually transmitted infections (STIs) could be a valuable addition to…
